| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.78▲ | 3.76▲ | 3.76▲ | 3.93▼ | 3.39▲ |
| MA10 | 3.77▲ | 3.74▲ | 3.76▲ | 3.76▲ | 3.06▲ |
| MA20 | 3.75▲ | 3.76▲ | 3.86▼ | 3.41▲ | 3.50▲ |
| MA50 | 3.75▲ | 3.96▼ | 3.87▼ | 3.01▲ | 3.12▲ |
| MA100 | 3.76▲ | 3.86▼ | 3.61▲ | 3.48▲ | 2.75▲ |
| MA200 | 3.92▼ | 3.57▲ | 3.18▲ | 3.26▲ | 2.81▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.016▲ | -0.012▼ | 0.047▲ | 0.040▲ |
| RSI | 65.859▲ | 51.028▲ | 47.506▼ | 61.816▲ | 56.334▲ |
| STOCH | 75.632 | 63.736 | 43.915 | 70.344 | 57.927 |
| WILL %R | -10.000▲ | -16.667▲ | -28.571 | -42.857 | -29.612 |
| CCI | 125.536▲ | 126.389▲ | 30.510 | 42.888 | 114.339▲ |
| CDL | $CRDF Doji Candlestick Pattern Detected | Set Alert |
|
Monday, June 02, 2025 09:57 PM
Cardiff Oncology, Inc. (NASDAQ:CRDF) announced groundbreaking Phase 1b clinical trial results for its PLK1 inhibitor onvansertib, combined with paclitaxel in metastatic triple-negative breast cancer ...
|
|
Wednesday, May 14, 2025 09:00 AM
Investors might want to bet on Cardiff Oncology (CRDF), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...
|
|
Wednesday, May 14, 2025 07:05 AM
Cardiff Oncology (NASDAQ:CRDF) has been on and off that high-priority list several times, but the conditions have prevented it from finding a spot in one of my portfolios. Now, CRDF is checking ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 3.78 | 3.87 | 3.67 | 3.81 | 997,600 |
| 12/06/25 | 3.88 | 3.93 | 3.72 | 3.79 | 866,500 |
| 11/06/25 | 4.32 | 4.38 | 3.80 | 3.87 | 1,558,700 |
| 10/06/25 | 3.925 | 4.355 | 3.91 | 4.30 | 1,821,793 |
| 09/06/25 | 3.92 | 3.98 | 3.685 | 3.86 | 959,326 |
| 06/06/25 | 3.65 | 3.93 | 3.61 | 3.88 | 1,152,400 |
| 05/06/25 | 3.64 | 3.73 | 3.57 | 3.62 | 738,600 |
| 04/06/25 | 3.54 | 3.84 | 3.50 | 3.62 | 1,606,946 |
| 03/06/25 | 3.38 | 3.605 | 3.326 | 3.51 | 839,207 |
| 02/06/25 | 3.47 | 3.58 | 3.33 | 3.35 | 1,431,166 |
|
|
||||
|
|
||||
|
|